Recreational use of marijuana during pregnancy and negative gestational and fetal outcomes: An experimental study in mice

Toxicology

Volumn 376, Issue , 2017, Pages 94-101

  Benevenuto, Sarah G ^a   Domenico, Marlise D ^a   Martins, Marco Antônio G ^a   Costa, Natália S ^a   de Souza, Ana Rosa L ^a   Costa, Jose L ^b   Tavares, Marina F M ^a   Dolhnikoff, Marisa ^a   Veras, Mariana Matera ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cannabis sativa; Embryo implantation; Fetal development; Pregnancy; Smoking

Indexed keywords

CANNABIS; STREET DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMICROSCOPY; BIRTH; BIRTH WEIGHT; BRAIN WEIGHT; CANNABIS USE; CONTROLLED STUDY; EXPERIMENTAL STUDY; FEMALE; FETUS; FETUS DEVELOPMENT; FETUS OUTCOME; FETUS WEIGHT; FOOD INTAKE; GESTATION LENGTH; LITTER SIZE; LIVER WEIGHT; LUNG WEIGHT; MALE; MATERNAL EXPOSURE; MOUSE; MOUSE MODEL; NONHUMAN; ORGAN WEIGHT; PARAMETERS CONCERNING THE FETUS, NEWBORN AND PREGNANCY; PLACENTA WEIGHT; PLACENTAL WET WEIGHT; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKE; THYMUS; THYMUS WEIGHT; URINE SAMPLING; UTERUS WEIGHT; WEIGHT GAIN; ADVERSE EFFECTS; ANIMAL; BAGG ALBINO MOUSE; CANNABIS SMOKING; CHEMICALLY INDUCED; DIAGNOSTIC IMAGING; DRUG EFFECTS; EATING; EXPOSURE; FETUS ECHOGRAPHY; PHYSIOLOGY; PRENATAL EXPOSURE;

ANIMALS; CANNABIS; EATING; FEMALE; FETAL DEVELOPMENT; INHALATION EXPOSURE; MALE; MARIJUANA SMOKING; MICE; MICE, INBRED BALB C; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; STREET DRUGS; ULTRASONOGRAPHY, PRENATAL;

EID: 84973582894     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2016.05.020     Document Type: Article

References (59)

1. Aban, C., Leguizamón, G.F., Cella, M., Damiano, A., Franchi, A.M., Farina, M.G., Differential expression of endocannabinoid system in normal and preeclamptic placentas: effects on nitric oxide synthesis. Placenta 34:1 (2013), 67–74, 10.1016/j.placenta.2012.10.009 (Epub 2012 Nov 1).
2. Abel, E.L., Cannabis: effects on hunger and thirst. Behav. Biol. 15:3 (1975), 225–281, 10.1016/S0091-6773(75)91684-3.
3. Abel, E.L., Effects of prenatal exposure to cannabinoids. NIDA Res. Monogr. 59 (1985), 20–35.
4. Abel, E.L., Bush, R., Dintcheff, B.A., Ernst, C.A., Critical periods for marihuana-induced intrauterine growth retardation in the rat. Neurobehav. Toxicol. Teratol. 3:3 (1981), 351–354.
5. American College of Obstetricians and Gynecologists (ACOG), Marijuana use during pregnancy and lactation. Committee Opinion No. 637. Obstet. Gynecol. 126 (2015), 234–238.
6. Alharbi, F.F., El-Guebaly, N., Exploring the management of cannabis use among women and during pregnancy. Addictive Disorders Treat. 13:2 (2014), 93–100, 10.1016/j.drugalcdep.2014.09.028.
7. Campolongo, P., Trezza, V., Ratano, P., Palmery, M., Cuomo, V., Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents. Psychopharmacology (Berl) 214:1 (2011), 5–15, 10.1007/s00213-010-1892-x.
8. Chan, H.W., McKirdy, N.C., Peiris, H.N., Rice, G.E., Mitchell, M.D., The role of endocannabinoids in pregnancy. Reproduction 146:3 (2013), 101–109, 10.1530/REP-12-0508.
9. Charlebois, A.T., Fried, P.A., Interactive effects of nutrition and cannabis upon rat perinatal development. Dev. Psychobiol. 13:6 (1980), 591–605, 10.1002/dev.420130605.
10. Choi, H., Rauh, V., Garfinkel, R., Tu, Y., Perera, F.P., Prenatal exposure to airborne polycyclic aromatic hydrocarbons and risk of intrauterine growth restriction. Environ. Health Perspect. 116:5 (2008), 658–665, 10.1289/ehp.10958.
11. Das, S.K., Paria, B.C., Chakraborty, I., Dey, S.K., Cannabinoid ligand- receptor signaling in the mouse uterus. Proc. Natl. Acad. Sci U. S. A. 92:10 (1995), 4332–4336, 10.1021/ja01062a046.
12. Donjacour, A., Liu, X., Lin, W., Simbulan, R., Rinaudo, P.F., In vitro fertilization affects growth and glucose metabolism in a sex-specific manner in an outbred mouse model. Biol. Reprod., 90(4), 2014, 80, 10.1095/biolreprod.113.113134.
13. El Marroun, H., Hudziak, J.J., Tiemeier, H., Creemers, H., Steegers, E.A., Jaddoe, V.W., Hofman, A., Verhulst, F.C., van den Brink, W., Huizink, A.C., Intrauterine cannabis exposure leads to more aggressive behavior and attention problems in 18-month-old girls. Drug Alcohol Depend. 118:2–3 (2011), 470–474, 10.1016/j.drugalcdep.2011.03.004.
14. Farhi, A., Boyko, V., Almagor, J., Benenson, I., Segre, E., Rudich, Y., Stern, E., Lerner-Geva, L., The possible association between exposure to air pollution and the risk for congenital malformations. Environ. Res. 135 (2014), 173–180, 10.1016/j.envres.2014.08.024.
15. Fleischman, R.W., Naqui, R.H., Rosenkrantz, H., Hayden, D.W., The embryotoxic effects of cannabinoids in rats and mice. J. Environ. Pathol Toxicol. 14:1 (1980), 1471–1482.
16. Fowden, A.L., Sferruzzi-Perri, A.N., Coan, P.M., Constancia, M., Burton, G.J., Placental efficiency and adaptation: endocrine regulation. J. Physiol. 587:14 (2009), 3459–3472, 10.1113/jphysiol.2009.173013.
17. Fried, P.A., Watkinson, B., Willan, A., Marijuana use during pregnancy and decreased length of gestation. Am. J. Obstet. Gynecol. 150:1 (1984), 23–27.
18. Fried, P.A., Charlebois, A.T., Effects upon rat offspring following Cannabis inhalation before and/or after mating. Can. J. Psychol. 33:3 (1979), 125–132.
19. Galiegue, S., Mary, S., Marchand, J., Dussossoy, D., Carriere, D., Carayon, P., Bouaboula, M., Shire, D., Le Fur, G., Casella, P., Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232:1 (1995), 54–61, 10.1111/j.1432-1033.1995.tb20780.x.
20. Gardner, D.K., Larman, M.G., Thouas, G.A., Sex-related physiology of the preimplantation embryo. Mol. Hum. Reprod. 16:8 (2010), 539–547, 10.1093/molehr/gaq042.
21. Gibson, G.T., Baghurst, P.A., Colley, D.P., Maternal alcohol, tobacco and cannabis consumption and the outcome of pregnancy. Aust. N. Z. J. Obstet. Gynaecol. 23:1 (1983), 15–19, 10.1111/j.1479-828X.1983.tb00151.x.
22. Gluckman, P.D., Hanson, M.A., Pinal, C., The developmental origins of adult disease. Matern. Child Nutr. 1:3 (2005), 130–141.
23. Habayeb, O.M., Taylor, A.H., Evans, M.D., Cooke, M.S., Taylor, D.J., Bell, S.C., Konje, J.C., Plasma levels of the endocannabinoid anandamide in women—a potential role in pregnancy maintenance and labor?. J. Clin. Endocrinol. Metab. 89:11 (2004), 5482–5487.
24. Harbison, R.D., Mantilla-Plata, B., Prenatal toxicity, maternal distribution and placental transfer of tetrahydrocannabinol. J. Pharmacol. Exp Ther. 180:2 (1972), 446–453.
25. Hayatbakhsh, M.R., Flenady, V.J., Gibbons, K.S., Kingsbury, A.M., Hurrion, E., Mamun, A.A., Najman, J.M., Birth outcomes associated with cannabis use before and during pregnancy. Pediatr. Res. 71:2 (2012), 215–219, 10.1038/pr.2011.25.
26. Higuera-Matas, A., Ucha, M., Ambrosio, E., Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes. Neurosci. Biobehav. Rev. 55 (2015), 119–146, 10.1016/j.neubiorev.2015.04.020.
27. Ho, B.T., Fritchie, G.E., Kralik, P.M., Englert, L.F., McIsaac, W.M., Idänpään-Heikkilä, J., Distribution of tritiated-1 delta 9tetrahydrocannabinol in rat tissues after inhalation. J. Pharm. Pharmacol. 22:7 (1970), 538–539.
28. Hudak, A., Ungváry, G., Embryotoxic effects of benzene and its methyl derivatives: toluene, xylene. Toxicology 11:1 (1978), 55–63.
29. Hurd, Y.L., Anderson, V., Beck, O., Minkoff, H., Dow-Edwards, D., Marijuana impairs growth in mid-gestation fetuses. Neurotoxicol. Teratol. 27:2 (2005), 221–229, 10.1016/j.ntt.2004.11.002.
30. Hutchings, D.E., Martin, B.R., Gamagaris, Z., Miller, N., Fico, T., Plasma concentrations of delta-9-tetrahydrocannabinol in dams and fetuses following acute or multiple prenatal dosing in rats. Life Sci. 44:11 (1989), 697–701.
31. Hutchings, D.E., Morgan, B., Brake, S.C., Shi, T., Lasalle, E., Delta-9-tetrahydrocannabinol during pregnancy in the rat: I. Differential effects on maternal nutrition, embryotoxicity, and growth in the offspring. Neurotoxicol. Teratol. 9:1 (1987), 39–43.
32. Jakubovic, A., Hattori, T., McGeer, P.L., Radiactivity in suckled rats after giving 14C-tetrahydrocannabinol to the mother. Eur. J. Pharmacol. 22:2 (1973), 221–223, 10.1016/0014-2999(73)90018-6.
33. Joneja, M.G., A study of teratological effects of intravenous, subcutaneous, and intragastric administration of delta9-tetrahydrocannabinol in mice. Toxicol. Appl. Pharmacol. 36:1 (1976), 151–162.
34. Khosho, F.K., Kaufmann, R.C., Amankwash, K.S., A simple and efficient method for obtaining urine samples from rats. Lab. Anim. Sci. 35:5 (1985), 513–514.
35. Kobayashi, S., Isotani, A., Mise, N., Yamamoto, M., Fujihara, Y., Kaseda, K., Nakanishi, T., Ikawa, M., Hamada, H., Abe, K., Okabe, M., Comparison of gene expression in male and female mouse blastocysts revealed imprinting of the X-linked gene, Rhox5/Pem, at preimplantation stages. Curr. Biol. 16:2 (2006), 166–172.
36. Kostellow, A.B., Bloch, E., Morrill, G.A., Fujimoto, G.I., Effects of cannabinoids on estrus cycle, reproductive capacity, and fetal development in A/J mice. Pharmacology, 31, 1978, 858.
37. Lichtman, A.H., Poklis, J.L., Poklis, A., Wilson, D.M., Martin, B.R., The pharmacological activity of inhalation exposure to marijuana smoke in mice. Drug Alcohol Depend. 63:2 (2001), 107–116.
38. Longo, L.D., The biological effects of carbon monoxide on the pregnant woman, fetus, and newborn infant. Am. J. Obstet. Gynecol. 129:1 (1977), 69–103.
39. Maccarrone, M., Endocannabinoid signaling in female reproductive events: a potential therapeutic target?. Expert Opin. Ther. Targets 19:11 (2015), 1423–1427, 10.1517/14728222.2015.
40. Mantilla-Plata, B., Clewe, G.L., Harbison, R.D., Delta9-Tetrahydrocannabinol-induced changes in prenatal growth and development of mice. Toxicol. Appl. Pharmacol. 33:2 (1975), 333–340.
41. Melford, S.E., Taylor, A.H., Konje, J.C., Of mice and (wo)men: factors influencing successful implantation including endocannabinoids. Hum. Reprod. Update 20:3 (2014), 415–428, 10.1093/humupd/dmt060.
42. Moir, D., Rickert, W.S., Levasseur, G., Larose, Y., Maertens, R., White, P., Desjardins, S., A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem. Res. Toxicol. 21:2 (2008), 494–502, 10.1021/tx700275p.
43. Mu, J., Adamson, S.L., Developmental changes in hemodynamics of uterine artery, utero- and umbilicoplacental, and vitelline circulations in mouse throughout gestation. Am. J. Physiol. Heart Circ. Physiol. 291:3 (2006), 1421–1428, 10.1152/ajpheart.00031.2006.
44. Murthy, N.V., Vassell, M., Melville, G.N., Wray, S.R., Ram, N.V., Haran, N.V., Reproductive toxicity of marihuana smoke. A three-generation study in female Wistar rats. West Indian Med. J. 35:2 (1986), 130–134.
45. Paria, B.C., Dey, S.K., Ligand- receptor signaling with endocannabinoids in preimplantation embryo development and implantation. Chem. Phys. Lipids 108:1 (2000), 211–220.
46. Park, B., Gibbons, H.M., Mitchell, M.D., Glass, M., Identification of the CB1 Cannabinoid receptor and fatty acid amine hydrolase (FAAH) in the human placenta. Placenta 24:5 (2003), 990–995, 10.1016/S0143-4004(03)00165-6.
47. Persaud, T.V.N., Ellington, A.C., Cannabis in early pregnancy. Lancet, 2, 1967, 1306.
48. Rosenkrantz, H., Fleischman, R.W., Barker, J.R., Embryotoxicity of marihuana by inhalation. Fed. Proc., 37, 1978, 737.
49. Sherwood, R.A., Keating, J., Kavvadia, V., Greenough, A., Peters, T.J., Substance misuse in early pregnancy and relationship to fetal outcomes. Eur. J Pediatr. 158:6 (1999), 488–492.
50. Sladek, S.M., Magness, R.R., Conrad, K.P., Nitric oxide and pregnancy. Am. J. Physiol. 272:2 Pt 2 (1997), 441–463.
51. Substance Abuse and Mental Health Services Administration, 2010. Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings (Office of Applied Studies, NSDUH Series H-38A, HHS Publication No. SMA 10-4586Findings). Rockville, MD.
52. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality (2015). Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health (HHS Publication No. SMA 15-4927, NSDUH Series H-50). Retrieved from http://www.samhsa.gov/data/.
53. Sun, X., Dey, S.K., Endocannabinoid signaling in female reproduction. ACS Chem. Neurosci. 3:5 (2012), 349–355, 10.1021/cn300014e.
54. Trezza, V., Campolongo, P., Cassano, T., Macheda, T., Dipasquale, P., Carratù, M.R., Gaetani, S., Cuomo, V., Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in Wistar rats. Psychopharmacology (Berl) 198:4 (2008), 529–537, 10.1007/s00213-008-1162-3.
55. United Nations Office on Drugs and Crime, World Drug Report, 2015. United Nations publication, Sales No. E.15. XI.6.
56. US Environmental Protection Agency, Guidelines for reproductive toxicity risk assessment. risk assessment forum. washington, DC. Fed. Regist. 61:212 (1996), 56274–56322.
57. Volkow, N.D., Baler, R.D., Compton, W.M., Weiss, S.R.B., Adverse health effects of marijuana use. N. Engl. J. Med. 370:23 (2014), 2219–2227, 10.1056/NEJMra1402309.
58. Wilson, M.E., Ford, S.P., Comparative aspects of placental efficiency. Reprod. Suppl. 58 (2001), 223–332.
59. Zuckerman, B., Frank, D.A., Hingson, R., Amaro, H., Levenson, S.M., Kayne, H., Parker, S., Vinci, R., Aboyage, K., Fried, L.E., Cabral, H., Timperi, R., Bauchner, H., Effects of maternal marijuana and cocaine use on fetal growth. N. Engl. J. Med. 320:12 (1989), 762–768, 10.1056/NEJM198903233201203.